Skip to content

Clinical trials

Intestinal Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intestinal Diseases Country / region: Netherlands Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20092
20131
20161
20172
20202
20211
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
AstraZeneca1
Hoffmann-La Roche1
Leiden University Medical Center1
Maastricht University1
Medtronic - MITG1
Pfizer1
Radboud University Medical Center1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intestinal Diseases16
Gastrointestinal Diseases9
Digestive System Diseases7
Colonic Diseases6
Gastrointestinal Neoplasms6
Intestinal Neoplasms6
Digestive System Neoplasms5
Colorectal Neoplasms4
Neoplasms4
Colonic Neoplasms3

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.